Novartis fined $49 million for bribing doctors to prescribe its drugs

Friday, April 28, 2017

Seoul: Swiss pharmaceutical company Novartis has been fined 55.1 billion won ($48.80 million) by the South Korean government for bribing doctors to prescribe its drugs. The government has also suspended insurance coverage for Novartis’ nine medicines for six months.

The ministry of health and welfare on Thursday said it has decided to take the punitive measures against Novartis, which is charged with offering 2.59 billion won to doctors from January 2011 to January 2016 in return for more prescriptions of its drugs, reports Korea Times.

The ministry’s decision means the nine medicines will remain expensive for the next six months without insurance reimbursement. “We will continue to try hard to root out such practices (bribing doctors) in the pharmaceutical industry with strong measures,” the ministry said in a statement.

Categories: NEWS, Pharmaceuticals

Tags: , , ,

  More from NEWS

Next generation optical biometry devices market may grow to $450 million by 2028

Healthcare should be a mission with ethical & moral values: Rajnath Singh

Biosense Technologies raises $1 million in funding

World No Tobacco Day celebrated at ESIC Medical College

Pune doctors perform India’s first uterus transplant surgery

ICMR to test efficacy of two medicines for tackling drug-resistant TB

Comments »

No comments yet.

Name (required)
E-mail (required - never shown publicly)
Your Comment (smaller size | larger size)
You may use <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> in your comment.